Rottapharm
Rottapharm's Irish operation in Damastown Industrial Park in Mulhuddart manufactures and sells drugs used in the treatment of osteo-arthritis, on behalf of its Italian parent Rottapharm/Madaus. It trades as Meda Manufacturing Dublin.
Financial Data
-
31st Dec 20 Source: CRO
- €143.6 million turnover
-
€24.3 million
profit - 306 employees
-
31st Dec 19 Source: CRO
- €143.2 million turnover
-
€49.9 million
profit - 233 employees
- 9 more years available »
Ranking
By Turnover
(€143.6 million)- 397th in Top Companies
- 40th in Pharma
- 61st in Manufacturing
By Employees
(306)- 499th in Top Companies
- 46th in Pharma
- 72nd in Manufacturing
-
- 306
- €143.6 million
Employees
- Patrick Garraghy CEO/Managing Director
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears